These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease. Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459 [TBL] [Abstract][Full Text] [Related]
7. Mathematical approach to understand the kinetics of alpha-synuclein aggregation: relevance to Parkinson's disease. Bharathi P; Nagabhushan P; Rao KS Comput Biol Med; 2008 Oct; 38(10):1084-93. PubMed ID: 18823621 [TBL] [Abstract][Full Text] [Related]
8. [The wild-type alpha-synuclein over-expression to induce the protein aberrant aggregation of alpha-synuclein in HEK293 cells in vitro]. Chen T; Tang BS; Liao XP; Yan XX; Zhang RX; Zhang YH; Tang JG; Cao L; Guo JF; Li J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):19-22. PubMed ID: 16456779 [TBL] [Abstract][Full Text] [Related]
9. Controlling the mass action of alpha-synuclein in Parkinson's disease. Kim C; Lee SJ J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382 [TBL] [Abstract][Full Text] [Related]
10. Selective detection, quantification, and subcellular location of alpha-synuclein aggregates with a protein aggregate filtration assay. Kramer ML; Behrens C; Schulz-Schaeffer WJ Biotechniques; 2008 Mar; 44(3):403-11. PubMed ID: 18361794 [TBL] [Abstract][Full Text] [Related]
11. The behavior of alpha-synuclein in neurons. Fortin DL; Nemani VM; Nakamura K; Edwards RH Mov Disord; 2010; 25 Suppl 1():S21-6. PubMed ID: 20187244 [TBL] [Abstract][Full Text] [Related]
12. Cytokines disrupt intracellular patterns of Parkinson's disease-associated proteins alpha-synuclein, tau and ubiquitin in cultured glial cells. Bick RJ; Poindexter BJ; Kott MM; Liang YA; Dinh K; Kaur B; Bick DL; Doursout MF; Schiess MC Brain Res; 2008 Jun; 1217():203-12. PubMed ID: 18501880 [TBL] [Abstract][Full Text] [Related]
13. Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein. Roberti MJ; Bertoncini CW; Klement R; Jares-Erijman EA; Jovin TM Nat Methods; 2007 Apr; 4(4):345-51. PubMed ID: 17351621 [TBL] [Abstract][Full Text] [Related]
14. Towards multiparametric fluorescent imaging of amyloid formation: studies of a YFP model of alpha-synuclein aggregation. van Ham TJ; Esposito A; Kumita JR; Hsu ST; Kaminski Schierle GS; Kaminski CF; Dobson CM; Nollen EA; Bertoncini CW J Mol Biol; 2010 Jan; 395(3):627-42. PubMed ID: 19891973 [TBL] [Abstract][Full Text] [Related]
17. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins. Schnack C; Danzer KM; Hengerer B; Gillardon F Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383 [TBL] [Abstract][Full Text] [Related]
18. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734 [TBL] [Abstract][Full Text] [Related]
19. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? Chu Y; Kordower JH Neurobiol Dis; 2007 Jan; 25(1):134-49. PubMed ID: 17055279 [TBL] [Abstract][Full Text] [Related]
20. The aggregation and fibrillation of alpha-synuclein. Fink AL Acc Chem Res; 2006 Sep; 39(9):628-34. PubMed ID: 16981679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]